HIT Consultant May 17, 2024
Fred Pennic

What You Should Know:

Implicity, a leader in remote patient monitoring and cardiac data management, has received FDA 510(k) clearance for SignalHF1, a groundbreaking new algorithm within their remote monitoring solution.

– SignalHF1 algorithm empowers early detection and intervention, paving the way for improved patient outcomes and a brighter future for cardiac care.

Leveraging Big Data for Better Heart Care

Implicity holds a unique distinction as the first private company to access the Health Data Hub, a vast repository of patient data on heart disease. By combining this comprehensive database with data from their AI-powered platform, Implicity’s team developed and validated SignalHF1. This machine learning algorithm analyzes data to assess a patient’s risk of future heart failure...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology
Getting Patients in the Habit of Doing the Right Thing
Teladoc expands virtual sitter capabilities
How Nurses Can Lead Innovation
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers
Singapore tackling chronic diseases with wearables

Share This Article